Pharvaris

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pharvaris 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PHVS

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. 

CEO
Berndt A. E. Modig
CEOBerndt A. E. Modig
Employees
129
Employees129
Headquarters
Leiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded
2015
Founded2015
Employees
129
Employees129

PHVS Key Statistics

Market cap
2.43B
Market cap2.43B
Price-Earnings ratio
-11.40
Price-Earnings ratio-11.40
Dividend yield
—
Dividend yield—
Average volume
589.11K
Average volume589.11K
High today
—
High today—
Low today
—
Low today—
Open price
$33.90
Open price$33.90
Volume
0.00
Volume0.00
52 Week high
$43.25
52 Week high$43.25
52 Week low
$21.02
52 Week low$21.02

Stock Snapshot

As of today, Pharvaris(PHVS) shares are valued at $34.75. The company's market cap stands at 2.43B, with a P/E ratio of -11.40.

On 2026-11-04, Pharvaris(PHVS) shares started trading at $33.90, with intraday highs of — and lows of —.

Trading volume for Pharvaris(PHVS) stock has reached 0, versus its average volume of 589.11K.

The stock's 52-week range extends from a low of $21.02 to a high of $43.25.

The stock's 52-week range extends from a low of $21.02 to a high of $43.25.

Analyst ratings

100%

of 15 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own PHVS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.